Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Supermax BhdSPMXF 46 Intrinsic Value: Projected FCF is $0.72 as of Sep. 21, 2026. GuruFocus rates SPMXF with a GF Score™ of 46/100 and a GF Value™ of $0.25. The stock has 5 warning signs investors should review. Among 413 Medical Devices & Instruments companies, Supermax Bhd ranks better than 98.31% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-09-21), Supermax Bhd's Intrinsic Value: Projected FCF is $0.72. The stock price of Supermax Bhd is $0.15. Therefore, Supermax Bhd's Price-to-Intrinsic-Value-Projected-FCF of today is 0.2.
The historical rank and industry rank for Supermax Bhd's Intrinsic Value: Projected FCF or its related term are showing as below:
SPMXF'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.13 Med: 0.47 Max: 2.53
Current: 0.21
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Supermax Bhd was 2.53. The lowest was 0.13. And the median was 0.47.
SPMXF's Price-to-Projected-FCF is ranked better than 98.31% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 1.46
vs SPMXF: 0.21
Supermax Bhd (OTCPK:SPMXF) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Supermax Bhd's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
0.15
/
0.5220709690437
=
0.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Supermax Bhd Intrinsic Value: Projected FCF Related Terms
Supermax Bhd Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Supermax Bhd's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SPMXF vs ISRG, BDX, RMD: Intrinsic Value: Projected FCF Comparison
For the Medical Instruments & Supplies subindustry, Supermax Bhd's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supermax Bhd Price-to-Projected-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Supermax Bhd's Price-to-Projected-FCF falls into.
Supermax Bhd Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $0.72 mean?
Supermax Bhd (SPMXF) has a Intrinsic Value: Projected FCF of $0.72 as of Sep. 21, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Supermax Bhd and its competitors. According to the industry distribution chart, Supermax Bhd ranks #7 out of 413 companies in the Medical Devices & Instruments industry, placing it in the top 1.7%.
Is Supermax Bhd's Intrinsic Value: Projected FCF too high?
Supermax Bhd's current Intrinsic Value: Projected FCF is $0.72. The Medical Devices & Instruments industry median Intrinsic Value: Projected FCF is 1.46. Supermax Bhd's value of $0.72 is 50.7% below this industry median. Based on the distribution chart, Supermax Bhd ranks #7 out of 413 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Supermax Bhd has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's Intrinsic Value: Projected FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Supermax Bhd ranks #7 out of 413 companies for Intrinsic Value: Projected FCF. This places Supermax Bhd in the top 2% of its industry — outperforming the majority of peers. The industry median Intrinsic Value: Projected FCF is 1.46. Supermax Bhd's value of $0.72 is 50.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Medical Devices & Instruments company?
The median Intrinsic Value: Projected FCF among Medical Devices & Instruments companies is 1.46, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supermax Bhd's current Intrinsic Value: Projected FCF of $0.72 is 50.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Supermax Bhd and its competitors. For the Medical Devices & Instruments industry, the median Intrinsic Value: Projected FCF is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supermax Bhd's current Intrinsic Value: Projected FCF is $0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Supermax Bhd (SPMXF) has a current Intrinsic Value: Projected FCF of $0.72. The stock's GF Value™ is $0.25, compared to a current price of $0.15 — trading 40% below its estimated fair value. The current Intrinsic Value: Projected FCF is $0.72 and 50.7% below the Medical Devices & Instruments industry median of 1.46. Supermax Bhd's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Supermax Bhd (SPMXF), the current Intrinsic Value: Projected FCF is $0.72 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supermax Bhd (SPMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued.
The current stock price of $0.15 is trading 40% below its estimated GF Value™ of $0.25.
Key valuation signals for SPMXF:
Intrinsic Value: Projected FCF: $0.72
GF Value™: $0.25 vs. price of $0.15 (40% below fair value)
Industry Position: 50.7% below the Medical Devices & Instruments median (#7 of 413)
No single metric tells the full story. See the SPMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
46GF Score
Get the complete analysis for SPMXF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPMXF has been successfully added to your 
